Although our results demonstrate that shikonin suppresses tumor cell aerobic glycolysis via inhibiting PKM2 phosphorylation, the molecular basis of reduction of PKM2 phosphorylation by shikonin remains unknown at this stage. Here, PKM is linked to neoplasm.